Early prediction of severity in acute pancreatitis using infrared spectroscopy of serum

Pancreatology

Volumn 7, Issue 5-6, 2007, Pages 451-458

  Petrov, Maxim S ^a,b   Gordetzov, Alexander S ^a   Kukosh, Mikhail V ^a  

^a PRIVOLZHSKY RESEARCH MEDICAL UNIVERSITY   (Russian Federation)

^b NONE   (Russian Federation)

Author keywords

Acute pancreatitis; Infrared spectroscopy; Prediction of severity

Indexed keywords

C REACTIVE PROTEIN;

ACUTE PANCREATITIS; ADULT; AGED; ARTICLE; DISEASE SEVERITY; FEMALE; HOSPITAL ADMISSION; HUMAN; INFRARED SPECTROSCOPY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; RATING SCALE; SENSITIVITY AND SPECIFICITY;

EID: 35348826196     PISSN: 14243903     EISSN: 14243911     Source Type: Journal    
DOI: 10.1159/000108962     Document Type: Article

References (43)

1. Banks PA, Freeman ML, the Practice Parameters Committee of the American College of Gastroenterology: Practice guidelines in acute pancreatitis. Am J Gastroenterol 2006;101:2379-2400.
2. Uhl W, Warshaw A, Imrie C, Bassi C, McKay CJ, Lankisch PG, Carter R, Di Magno E, Banks PA, Whitcomb DC, Dervenis C, Ulrich CD, Satake K, Ghaneh P, Hartwig W, Werner J, McEntee G, Neoptolemos JP, Büchler M: IAP guidelines for the surgical management of acute pancreatitis. Pancreatology 2002;2:565-573.
3. Working Party of the British Society of Gastroenterology; Association of Surgeons of Great Britain and Ireland; Pancreatic Society of Great Britain and Ireland; Association of Upper GI Surgeons of Great Britain and Ireland: UK guidelines for the management of acute pancreatitis. Gut 2005;54(suppl 3):1-9.
4. Wyncoll DL: The management of severe acute necrotizing pancreatitis: an evidence-based review of the literature. Intensive Care Med 1999;25:146-156.
5. Johnson CD, Abu-Hilal M: Persistent organ failure during the first week as a marker of fatal outcome in acute pancreatitis. Gut 2004;53:1340-1344.
6. Williams M, Simms HH: Prognostic usefulness of scoring systems in critically ill patients with severe acute pancreatitis. Crit Care Med 1999;27:901-907.
7. Marik P, Zaloga G: Meta-analysis of parenteral nutrition versus enteral nutrition in patients with acute pancreatitis. BMJ 2004;328:1407-1412.
8. Petrov MS, Kukosh MV, Emelyanov NV: A randomized controlled trial of enteral versus parenteral feeding in patients with predicted severe acute pancreatitis shows a significant reduction in mortality and in infected pancreatic complications with total enteral nutrition. Dig Surg 2006;23:336-344.
9. Wilson C, Health DI, Imrie CW: Prediction of outcome in acute pancreatitis: a comparative study of APACHE II, clinical assessment and multiple factor scoring systems. Br J Surg 1990;77:1260-1264.
10. Rau B, Schilling MK, Beger HG: Laboratory markers of severe acute pancreatitis. Dig Dis 2004;22:247-257.
11. Robert J, Frossard JL, Mermillod B: Early prediction of acute pancreatitis: prospective study comparing CT scans, Ranson, Glasgow, APACHE II scores, and various serum markers. World J Surg 2002;26:612-619.
12. Lempinen M, Puolakkainen P, Kemppainen E: Clinical value of severity markers in acute pancreatitis. Scand J Surg 2005;94:118-123.
13. Kemppainen E, Sainio V, Haapiainen R, Kivisaari L, Kivilaakso E, Puolakkainen P: Early localization of necrosis by contrast-enhanced computed tomography can predict outcome in severe acute pancreatitis. Br J Surg 1996;83:924-929.
14. 2-weighted and dynamic enhanced MRI in acute pancreatitis: comparison with contrast enhanced CT. Clin Radiol 1997;52:109-114.
15. Pearce CB, Gunn SR, Ahmed A, Johnson CD: Machine learning can improve prediction of severity in acute pancreatitis using admission values of APACHE II score and C-reactive protein. Pancreatology 2006;6:123-131.
16. Keogan MT, Lo JY, Freed KS, Raptopoulos V, Blake S, Kamel IR, Weisinger K, Rosen MP, Nelson RC: Outcome analysis of patients with acute pancreatitis by using an artificial neural network. Acad Radiol 2002;9:410-419.
17. Losanoff JE, Asparouhov OK, Jones JW: Multiple factor scoring system for risk assessment of acute pancreatitis. J Surg Res 2001;101:73-78.
18. Eachempati SR, Hydo LJ, Barie PS: Severity scoring for prognostication in patients with severe acute pancreatitis. Comparative analysis of the Ranson score and the APACHE III score. Arch Surg 2002;137:730-736.
19. Frossard JL, Hadengue A, Pastor CM: New serum markers for the detection of severe acute pancreatitis in humans. Am J Respir Crit Care Med 2001;164:162-170.
20. Hall JW, Pollard A: Near-infrared spectrophotometry: a new dimension in clinical chemistry. Clin Chem 1992;38:1623-1631.
21. Shaw RA, Kotowich S, Leroux M, Mantsch HH: Multianalyte serum analysis using midinfrared spectroscopy. Ann Clin Biochem 1998;35:624-632.
22. Werner GH, Fruh J, Keller F, Greger H, Somorjai R, Dolenko B, Otto M, Bocker D: Mid-infrared spectroscopy as a tool for disease pattern recognition from human blood. Proc SPIE 1998;3257:35-41.
23. Petrich W, Dolenko B, Fruh J, Ganz M, Greger H, Jacob S: Disease pattern recognition in infrared spectra of human sera with diabetes mellitus as an example. Appl Opt 2000;39:3372-3379.
24. Staib A, Dolenko B, Fink DJ, Fruh J, Nikulin AE, Otto M, Pessin-Minsley MS, Quarder O, Somorjai R, Thienel U, Werner G, Petrich W: Disease pattern recognition testing for rheumatoid arthritis using infrared spectra of human serum. Clin Chim Acta 2001;308:79-89.
25. Sakudo A, Tsenkova R, Onozuka T, Morita K, Li S, Warachit J, Iwabu Y, Li G, Onodera T, Ikuta K: A novel diagnostic method for human immunodeficiency virus type-1 in plasma by near-infrared spectroscopy. Microbiol Immunol 2005;49:695-701.
26. Dominguez-Munoz E, Carballo F, Garcia MJ: Evaluation of the clinical usefulness of APACHE II and SAPS systems in the initial prognostic classification of acute pancreatitis: a multicenter study. Pancreas 1993;8:682-686.
27. Andren-Sandberg A, Borgstrom A: Early prediction of severity in acute pancreatitis. Is this possible? JOP 2002;3:116-125.
28. Bradley EL 3rd: A clinically based classification system for acute pancreatitis. Summary of the International Symposium on Acute Pancreatitis, Atlanta, Ga, September 11-13, 1992. Arch Surg 1993;128:586-590.
29. Marshall JC, Cook DJ, Christou NV, Bernard GR, Sprung CL, Sibbald WJ: Multiple organ dysfunction score: reliable descriptor of a complex clinical outcome. Crit Care Med 1995;23:1638-1652.
30. Ciurczak EW, Drennen JK: Pharmaceutical and Medical Application of Near-Infrared Applications (Practical Spectroscopy). New York, Dekker, 2002, p 115.
31. Petrov MS, Gordetzov AS, Emelyanov NV: Usefulness of infrared spectroscopy in diagnosis of acute pancreatitis. ANZ J Surg 2007;77:347-351.
32. Swets JA: Measuring the accuracy of diagnostic systems. Science 1988;240:1285-1293.
33. Zweig MH, Campbell G: Receiver-operating characteristic plots: a fundamental evaluation tool in clinical medicine. Clin Chem 1993;39:561-577.
34. Romagnuolo J, Barkun AB, Joseph L: Interpretation of diagnostic tests; in Rosenberg L, Joseph L, Barkun AN (eds): Surgical Arithmetic: Epidemiological, Statistical and Outcome-Based Approach to Surgical Practice. Georgetown/Tex, Landes Bioscience, 2000, chapt 3, pp 64-83.
35. Heinrich S, Schafer M, Rousson V, Clavien PA: Evidence-based treatment of acute pancreatitis: a look at established paradigms. Ann Surg 2006;243:154-168.
36. Dervenis CG: Staging acute pancreatitis. Where are we now? Pancreatology 2001;1:201-206.
37. Neoptolemos JP, Rarty M, Finch M, Sutton R: Acute pancreatitis: the substantial human and financial cases. Gut 1998;42:886-891.
38. Larvin M, McMahon MJ: APACHE II score for assessment and monitoring of acute pancreatitis. Lancet 1989;ii:201-205.
39. Fan ST, Lai EC, Mok FP, Lo CM, Zheng SS, Wong J: Prediction of the severity of acute pancreatitis. Am J Surg 1993;166:262-268.
40. Neoptolemos JP, Kemppainen EA, Mayer JM, Fitzpatrick JM, Raraty MG, Slavin J, Beger HG, Hietaranta AJ, Puolakkaien PA: Early prediction of severity in acute pancreatitis by urinary trypsinogen activation peptide: a multicentre study. Lancet 2000;355:1955-1960.
41. Kylanpaa-Back ML, Takala A, Kemppainen EA, Puolakkainen PA, Leppaniemi AK, Karonen SL, Orpana A, Haapiainen RK, Repo H: Procalcitonin, soluble interleukin-2 receptor, and soluble E-selectin in predicting the severity of acute pancreatitis. Crit Care Med 2001;29:63-69.
42. Mayer JM, Raraty M, Slavin J, Kemppainen E, Fitzpatrick J, Hietaranta A, Puolakkainen P, Beger HG, Neoptolemos JP: Serum amyloid A is a better early predictor of severity than C-reactive protein in acute pancreatitis. Br J Surg 2002;89:163-171.
43. Rau B, Steinbach G, Baumgart K, Gansauge F, Grunert A, Beger HG: Serum amyloid A versus C-reactive protein in acute pancreatitis: clinical value of an alternative acutephase reactant. Crit Care Med 2000;28:736-742.